AGEN Stock Analysis: Buy, Sell, or Hold?
AGEN - Agenus Inc.
$2.90
0.04 (1.40%)
▲
5d:
-9.09%
30d:
-10.22%
90d:
-26.95%
HOLD
MODERATE Confidence
Last Updated: February 3, 2026
Earnings: Mar 10, 2026
Get Alerted When AGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called AGEN this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AGEN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: AGEN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$20.27
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$12.59
77.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AGEN is currently trading at $2.90, which is considered oversold relative to its 30-day fair value range of $2.94 to $3.90. From a valuation perspective, the stock is trading at a discount (Forward PE: 1.5) compared to its historical average (7.4). Remarkably, the market is currently pricing in an annual earnings decline of 41.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, AGEN is in a downtrend. Immediate support is located at $2.80, while resistance sits at $3.55.
Market Sentiment: AGEN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.33 (+325.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AGEN is in a downtrend. Immediate support is located at $2.80, while resistance sits at $3.55.
Market Sentiment: AGEN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.33 (+325.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.94 -
$3.90
Company Quality Score
46/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
59.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 325.3% below Wall St target ($12.33)
- CAUTION: 5-day price weakness (-9.1%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$2.94 -
$3.90
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.69
(23.8%)
Support & Resistance Levels
Support Level
$2.80
Resistance Level
$3.55
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
1.48
Wall Street Target
$12.33
(+325.3%)
Revenue Growth (YoY)
20.4%
Profit Margin
-32.9%
Valuation Discount vs History
-41.6% cheaper
PE vs Historical
1.5 vs 7.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-41.6%
(market-implied from PE analysis)
1-Year Target
$2.61
(-10%)
2-Year Target
$2.35
(-19%)
3-Year Target
$2.11
(-27%)
3-Yr Target (if PE normalizes)
(PE: 1→7)
$10.55
(+264%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 1.5 to 7.4
Stabilization Target:
$14.47
(+398.9%)
PE Expansion Potential:
+398.9%
Last updated: February 03, 2026 6:46 PM ET
Data refreshes hourly during market hours. Next update: 7:46 PM
Data refreshes hourly during market hours. Next update: 7:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$89 | 62 BUY |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$215 | 58 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$217 | 59 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$31 | 60 BUY |
|
VERA
Vera Therapeutics Inc |
STRONG BUY
14 analysts |
$75 | 54 HOLD |
